Science Explorer Interactive view Map
Company · San Francisco · United States

Theravance Biopharma (United States)

In research, Theravance Biopharma (United States) stands highest in Medicine (#13,924 of 17,978 worldwide) and Health Sciences (#17,045 of 20,462 worldwide), over all time.

theravance.comROR OpenAlex
World rank, all time
#23,710
of 42,892
Rank in United States
#5,098
of 8,685
Research works
272
▲ 18% vs 2013–17
Citations
6.3k
23.1 per fractional work
Top-10% rate
5.6%
record average 16.5%
Open access
50%
world 28%

What is Theravance Biopharma (United States) known for in research?

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

FieldWorld rankWhere that sitsTop-10% rateWorks
MedicineField #13,924 of 17,978 19.7%159
Health SciencesDomain #17,045 of 20,462 19.8%163

Each strip is that field’s whole ranked pool, with the notch where Theravance Biopharma (United States) sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.04× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 2.93× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 6.79× its world share, 3 worksImmunology and Micro…Neuroscience: 0.53× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.34× its world share, 1 worksPharmacology, Toxico…Chemistry: 2.25× its world share, 1 worksChemistryComputer Science: 0.69× its world share, 2 worksComputer ScienceEngineering: 0.01× its world share, 0 worksEngineeringEnvironmental Science: 0.17× its world share, 0 worksEnvironmental ScienceDentistry: 0.25× its world share, 0 worksDentistryHealth Professions: 0.97× its world share, 1 worksHealth ProfessionsMedicine: 2.84× its world share, 21 worksMedicineArts and Humanities: 0.13× its world share, 0 worksArts and HumanitiesBusiness, Management and Accounting: 0.02× its world share, 0 worksBusiness, Management…Psychology: 0.28× its world share, 0 worksPsychologySocial Sciences: 0.40× its world share, 2 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.3×. Every wedge is a field page.

Who are the top researchers at Theravance Biopharma (United States)?

Ranked on the composite score, Friedrich Graf Finckenstein, Glenn Crater and Sharath S. Hegde lead among researchers whose main affiliation is Theravance Biopharma (United States).

  1. 1 Friedrich Graf Finckenstein United States · #376,425 worldwide 80 citations · 18 works
  2. 2 Glenn Crater United States · #1,347,334 worldwide 6 citations · 16 works
  3. 3 Sharath S. Hegde United States · #1,423,472 worldwide 18 citations · 15 works
  4. 4 Yuhua Ji United States · #1,501,933 worldwide 24 citations · 15 works
All ranked researchers at Theravance Biopharma (United States)

Which keywords describe research at Theravance Biopharma (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Tumor Microenvironment, CAR T Cells, Chimeric Antigen Receptor, Gene Therapy and Bacterial Therapy.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Immunotherapy6▲ 21×7 topics
  2. Tumor Regression5▲ 116×2 topics
  3. Cancer Immunotherapy4▲ 72×3 topics
  4. Tumor Microenvironment3▲ 19×4 topics
  5. Inflammation3▲ 3.5×12 topics
  6. CAR T Cells3▲ 92×1 topic
  7. Chimeric Antigen Receptor3▲ 92×1 topic
  8. Gene Therapy3▲ 35×2 topics
  9. Bacterial Therapy2▲ 166×1 topic
  10. Tumor Targeting2▲ 33×1 topic
  11. Immunity2▲ 14×4 topics
  12. Cancer2▲ 3.7×5 topics
  13. Diagnosis2▲ 5.4×5 topics
  14. Immune Checkpoint Blockade2▲ 47×1 topic
  15. PD-1 and PD-L12▲ 47×1 topic
  16. Immune Response2▲ 8.4×6 topics
  17. Antigen Presentation2▲ 51×2 topics
  18. Dendritic Cells2▲ 47×1 topic
  19. Innate Immunity2▲ 14×2 topics
  20. Nanoparticles2▲ 3.5×2 topics
  21. Tumor Antigen2▲ 69×1 topic
  22. Management2▲ 4.7×3 topics
  23. Global Burden1▲ 6.0×2 topics
  24. Knowledge Management1▲ 6.2×2 topics
  25. Pulmonary Hypertension1▲ 23×2 topics
  26. COPD1▲ 48×1 topic
  27. Inhaler Devices1▲ 123×1 topic
  28. Pulmonary Drug Delivery1▲ 123×1 topic
  29. spirometry1▲ 48×1 topic
  30. Endothelial Dysfunction1▲ 12×2 topics
  31. Genetic Mutations1▲ 6.4×4 topics
  32. Treatment Guidelines1▲ 13×2 topics
  33. Data Integration1▲ 15×2 topics
  34. Echocardiography1▲ 9.4×1 topic
  35. Ethical Climate1▲ 86×1 topic
  36. IL-61▲ 116×1 topic
  37. Mitochondrial Dysfunction1▲ 8.9×4 topics
  38. Moral Distress1▲ 86×1 topic
  39. Right Heart Assessment1▲ 64×1 topic
  40. STAT31▲ 116×1 topic

Which research topics does Theravance Biopharma (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Cancer Research and Treatments, Cancer Immunotherapy and Biomarkers and Immunotherapy and Immune Responses.

CAR-T cell therapy research: 3 fractional worksCancer Research and Treatments: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksImmunotherapy and Immune…2Immunotherapy and Immune Responses: 2 fractional worksInhalation and Respiratory Drug Delivery: 1 fractional worksChronic Obstructive Pulmonary Disease (COPD) Research: 1 fractional worksPulmonary Hypertension R…1Pulmonary Hypertension Research and Treatments: 1 fractional worksCytokine Signaling Pathways and Interactions: 1 fractional worksEthics in medical practice: 1 fractional worksBiomedical Text Mining and Ontologies: 1 fractional works
OncologyBiotechnologyImmunologyPulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Cancer Research and Treatments Biotechnology 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 Immunotherapy and Immune Responses Immunology 2 works
  5. 5 Inhalation and Respiratory Drug Delivery Pulmonary and Respiratory Medicine 1 works
  6. 6 Chronic Obstructive Pulmonary Disease (COPD) Research Pulmonary and Respiratory Medicine 1 works
  7. 7 Pulmonary Hypertension Research and Treatments Pulmonary and Respiratory Medicine 1 works
  8. 8 Cytokine Signaling Pathways and Interactions Oncology 1 works
  9. 9 Ethics in medical practice General Health Professions 1 works
  10. 10 Biomedical Text Mining and Ontologies Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.5%not open49.5%

World: 28% of research is openly available.

with international co-authors15.9%domestic only84.1%

World: 19% is written across borders.

How has Theravance Biopharma (United States)'s research output changed?

Output in 2018–2022 was 18% higher than in 2013–2017.

2005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Francisco

All research institutions in San Francisco

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.